Axsome

AXSM NASDAQ
23.08
-0.32
-1.37%
Pre Market: 23.68 +0.6 +2.60% 09:04 05/20 EDT
Open
23.32
Prev Close
23.40
High
24.22
Low
22.90
Volume
2.95K
Avg Vol (3M)
1.28M
52 Week High
24.22
52 Week Low
1.940
% Turnover
0.01%
Market Cap
768.69M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Axsome AXSM stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02 (disodium zoledronate tetrahydrate), is an oral, targeted, non opioid therapeutic for chronic pain. It is developing AXS 02 for the treatment of pain in over three conditions, such as complex regional pain syndrome (CRPS); knee osteoarthritis (OA) associated with bone marrow lesions (BMLs), and chronic low back pain (CLBP), associated with type I, or mixed type I and type II Modic changes (MCs). Its product candidate, AXS 05, is a fixed dose combination of dextromethorphan (DM) and bupropion. It is developing AXS 05 for the treatment of over two conditions, such as treatment resistant depression (TRD), and agitation in patients with Alzheimer's disease (AD).
MORE >

Recently

Name
Price
%Change